My understanding is Azer-Cel targets CD-19 which is not normally expressed on myeloid lineage cancers like AML so no.
CAR-T hasn't been a huge commercial success in AML to date for a number of reasons.
My understanding is Azer-Cel targets CD-19 which is not normally...
-
- There are more pages in this discussion • 3,569 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IMU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
5.4¢ |
Change
0.002(3.85%) |
Mkt cap ! $396.8M | |||
| Open | High | Low | Value | Volume |
| 5.2¢ | 5.4¢ | 5.2¢ | $360.3K | 6.803M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 22 | 1826300 | 5.2¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 5.4¢ | 2962204 | 7 |
View Market Depth
| Last trade - 16.10pm 21/08/2024 (20 minute delay) ? |
| IMU (ASX) Chart |